Urticaria: New Insights into Pathogenesis, Diagnosis and Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 809
Special Issue Editor
Interests: food allergy; metal allergy; drug allergy; nasal cytology; immunotherapy; asthma; rhinitis; nasal polyposis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Urticaria is a predominantly mast cell-driven disease clinically characterized by wheals and/or angioedema. The etiopathogenesis of this disease is complex and unclear. Since chronic spontaneous urticaria is idiopathic, the search for causes, the optimization of treatment and the multidisciplinary approach to the disease are the pillars of research on this pathology. In addition, in recent years, significant advances in understanding the pathophysiological mechanisms of urticaria have prompted researchers to explore new drugs, particularly biologics, for patients with severe refractory urticaria.
In this Special Issue, we welcome papers (reviews and original articles) that will cover all aspects of urticaria, which include the following:
- Urticaria in special settings: childhood, pregnancies, and immunodeficiencies;
- Emerging pathophysiological aspects;
- Diagnostic work-up;
- Biomarkers of disease activity/severity and of the response to treatment;
- Current and future therapeutic targets.
Dr. Angela Rizzi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute urticaria
- chronic urticaria
- pathogenesis
- mast cells
- biomarkers
- diagnosis
- biologicals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
